This past week, David H. Crean, PhD, Managing Director and head of our Life Sciences and Healthcare Practice Group, spent time reviewing the >400 life science opportunities that were presented to him and our investment banking firm in 2017 in which entrepreneurs and business owners were looking for either capital financing, sell-side M&A, strategic advisory services or partnering/ licensing. Nearly invariably, each investment pitch lacked the complete and necessary material to tell the comprehensive story that would be compelling for an investor to write a check. These entrepreneurs are very smart and passionate about their mission but need to recognize and think like investors or strategic buyers. Investors see and hear many investment opportunities and you need to be differentiated and stand out from the masses.(more…)
"Working with life science companies is not like serving other industries. There are myriad legal and financial eccentricities - accounting for multiple financing sources makes accounting especially complex, for instances and protecting intellectual property is key. Early-stage companies may need their hand held as they focus on the science and outsource everything else." San Diego Business Journal
From the moment you make a decision to set up and operate a business, you’re in the “business lifecycle.” Fasten your seatbelt before the drive as you’ll journey from idea to startup, and if successful, through to the growth and maturity phases. Each stage of the lifecycle has a unique set of obstacles to deal with and overcome. Being flexible in your thinking and adapting your strategy as you move along will serve you well. This not only applies to a business strategy but also to the financial plans to support the development and growth of the Company. A capital financing strategy should summarize investor targets for outreach by stage of the lifecycle, inflection points and how these will change valuation, and the actions to be taken over a three-to-five year period to achieve the company's goals in its business evolution. Putting together the strategy is hard work that takes time and considerable thought. Raising money is also hard work, so get started today.(more…)
Objective Capital’s David H. Crean to Serve as Guest Panelist at LaunchBio Event, November 14, 2017
San Diego, November 9, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been invited to speak as a guest panelist at LaunchBio Series Event for life science companies entitled BIO Buck$ Fast Forward: A Start-ups Guide to Investment Banks. Dr. Crean will be joined by Charlie Adams, Cantor Fitzgerald and Tony Grover, VP of Business Development at Banyan Biomarker.(more…)
Join CohnReznick, Objective Capital Partners, Wilson Sonsini and an Exclusive Group of Life Science Executives for Engaging Discussion on May 17
San Diego, CA- April 18, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that they have teamed up with CohnReznick and Wilson Sonsini Goodrich & Rosati to sponsor a Roundtable discussion on Private Capital Raising for Life Science Companies on Wednesday, May 17, 2017. The Roundtable discussion will take place from 7:30-9:00 am at Barney & Barney in San Diego, CA.(more…)
San Diego, CA- February 3, 2017 - Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors and Head of its Life Sciences and Healthcare practice, will be a guest panelist speaker at Association of Corporate Counsel (ACC) of San Diego on March 2, 2017 from 5:00-6:30 PM. Dr. Crean will be joined by fellow panelists Dennis Doucette, Partner, Corporate & Securities, Practice Group Leader for Procopio, and David Szekeres, Senior Vice President, Business Development, General Counsel and Corporate Secretary for Heron Therapeutics, Inc. The panel will address Current Capital Raising Issues and Strategies for Biotech Companies. The event will be held at the offices of Procopio, Cory, Hargreaves & Savitch LLP, 12544 High Bluff Drive, Suite 300, San Diego, CA 92130.(more…)
San Diego, CA- January 14, 2017 - Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that Trever Acers, one of its Managing Directors, will be a guest panelist speaker at the CFO Leadership Council on February 16, 2017 from 7:15-9:30 AM. Mr. Acers will be joined by fellow panelists Craig Dupper, Managing Partner at Solis Capital Partners, Michael Umansky, Partner at Sheppard Mullin Richter & Hampton LLP and Gordon Wiens, Senior Vice President at Bank of America. The panel discussion will be moderated by Daniel Bruckart, VP & Relationship Manager at Bank of America Merrill Lynch. The panel will address Obtaining Capital: Debt and Equity. The event will be held at the offices of KPMG, 4747 Executive Drive, San Diego CA 92121.(more…)
San Diego, CA- October 20, 2016 - Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500MM, is pleased to announce an expansion of their transactional and advisory services with the establishment of its Lower Middle Market Investment Banking Practice (LMM). The LMM Practice applies Objective Capital’s highly engineered transaction processes to serve entrepreneur-led companies having revenues of $3-15MM, assisting business owners with mergers & acquisitions and capital raising transactions.
San Diego, CA – October 5, 2016- Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors, has been invited to serve as moderator for a seminar on Healthcare Investments as part of a full-day discussion on Family Office Trends. The event is hosted by Ivy Family Office Network (IvyFON) and will be held on Thursday, October 20th at the offices of Morrison Foerster, 12531 High Bluff Drive, San Diego, CA 92130. A reception will immediately follow the event.(more…)
This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.